Egerton A - Search Results

1

Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration.

Egerton A, Griffiths K, Casetta C, Deakin B, Drake R, Howes OD, Kassoumeri L, Khan S, Lankshear S, Lees J, Lewis S, Mikulskaya E, Millgate E, Oloyede E, Pollard R, Rich N, Segev A, Sendt KV, MacCabe JH. Egerton A, et al. Neuropsychopharmacology. 2023 Feb;48(3):567-575. doi: 10.1038/s41386-022-01508-w. Epub 2022 Dec 1. Neuropsychopharmacology. 2023. PMID: 36456813 Free PMC article.

2

Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia.

Egerton A, Reid L, McKerchar CE, Morris BJ, Pratt JA. Egerton A, et al. Psychopharmacology (Berl). 2005 Apr;179(1):77-84. doi: 10.1007/s00213-004-2109-y. Epub 2005 Jan 29. Psychopharmacology (Berl). 2005. PMID: 15682304

3

Cannabinoids and prefrontal cortical function: insights from preclinical studies.

Egerton A, Allison C, Brett RR, Pratt JA. Egerton A, et al. Neurosci Biobehav Rev. 2006;30(5):680-95. doi: 10.1016/j.neubiorev.2005.12.002. Epub 2006 Mar 29. Neurosci Biobehav Rev. 2006. PMID: 16574226 Review.

4

Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopy.

Goggi JL, Sardini A, Egerton A, Strange PG, Grasby PM. Goggi JL, et al. Among authors: egerton a. Synapse. 2007 Apr;61(4):231-41. doi: 10.1002/syn.20360. Synapse. 2007. PMID: 17230553

5

Modelling prefrontal cortex deficits in schizophrenia: implications for treatment.

Pratt JA, Winchester C, Egerton A, Cochran SM, Morris BJ. Pratt JA, et al. Among authors: egerton a. Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S465-70. doi: 10.1038/bjp.2008.24. Br J Pharmacol. 2008. PMID: 18311160 Free PMC article. Review.

6

The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study.

Montgomery AJ, Lingford-Hughes AR, Egerton A, Nutt DJ, Grasby PM. Montgomery AJ, et al. Among authors: egerton a. Synapse. 2007 Aug;61(8):637-45. doi: 10.1002/syn.20419. Synapse. 2007. PMID: 17492764

7

Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge.

Stokes PR, Egerton A, Watson B, Reid A, Breen G, Lingford-Hughes A, Nutt DJ, Mehta MA. Stokes PR, et al. Among authors: egerton a. Neuroimage. 2010 Oct 1;52(4):1521-7. doi: 10.1016/j.neuroimage.2010.04.274. Epub 2010 May 6. Neuroimage. 2010. PMID: 20451621

8

Striatal dopamine (D2) receptor availability predicts socially desirable responding.

Reeves SJ, Mehta MA, Montgomery AJ, Amiras D, Egerton A, Howard RJ, Grasby PM. Reeves SJ, et al. Among authors: egerton a. Neuroimage. 2007 Feb 15;34(4):1782-9. doi: 10.1016/j.neuroimage.2006.10.042. Epub 2006 Dec 26. Neuroimage. 2007. PMID: 17188897

9

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.

Egerton A, Reid L, McGregor S, Cochran SM, Morris BJ, Pratt JA. Egerton A, et al. Psychopharmacology (Berl). 2008 May;198(1):37-49. doi: 10.1007/s00213-008-1071-5. Epub 2008 Apr 23. Psychopharmacology (Berl). 2008. PMID: 18427784

10

Functionally defined regions may aid interpretation of striatal dopamine elevation in schizophrenia.

Egerton A, McGuire PK, Howes OD. Egerton A, et al. Schizophr Res. 2009 Apr;109(1-3):200. doi: 10.1016/j.schres.2009.02.004. Epub 2009 Feb 27. Schizophr Res. 2009. PMID: 19250801 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters